Brokerages expect MAXIMUS, Inc. (NYSE:MMS) to post earnings per share of $0.77 for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for MAXIMUS’s earnings, with estimates ranging from $0.75 to $0.79. MAXIMUS reported earnings of $0.71 per share during the same quarter last year, which indicates a positive year over year growth rate of 8.5%. The company is scheduled to issue its next earnings results on Thursday, February 8th.

On average, analysts expect that MAXIMUS will report full year earnings of $3.05 per share for the current financial year, with EPS estimates ranging from $3.00 to $3.11. For the next year, analysts forecast that the business will post earnings of $3.33 per share, with EPS estimates ranging from $3.28 to $3.40. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that that provide coverage for MAXIMUS.

Several research firms have weighed in on MMS. Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $73.00 target price for the company in a research note on Wednesday, October 4th. Canaccord Genuity restated a “buy” rating on shares of MAXIMUS in a research note on Wednesday, December 27th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $64.33.

In other news, CEO Richard A. Montoni sold 30,000 shares of the stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $69.25, for a total value of $2,077,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Russell A. Beliveau sold 1,000 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $71.73, for a total value of $71,730.00. The disclosure for this sale can be found here. Insiders have sold 71,417 shares of company stock valued at $4,902,785 over the last 90 days. Corporate insiders own 3.10% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in MMS. Acrospire Investment Management LLC lifted its stake in shares of MAXIMUS by 17.6% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,000 shares of the health services provider’s stock valued at $125,000 after acquiring an additional 300 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of MAXIMUS by 10.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock valued at $148,000 after acquiring an additional 220 shares during the last quarter. Intl Fcstone Inc. bought a new position in shares of MAXIMUS in the 2nd quarter valued at $201,000. OLD National Bancorp IN bought a new position in shares of MAXIMUS in the 3rd quarter valued at $246,000. Finally, Cubist Systematic Strategies LLC lifted its stake in shares of MAXIMUS by 16.0% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock valued at $249,000 after acquiring an additional 546 shares during the last quarter. Institutional investors own 94.79% of the company’s stock.

Shares of MAXIMUS (NYSE:MMS) opened at $71.27 on Wednesday. MAXIMUS has a 12-month low of $51.74 and a 12-month high of $72.54. The stock has a market capitalization of $4,626.65, a P/E ratio of 22.84, a P/E/G ratio of 2.67 and a beta of 1.34.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2018/01/06/zacks-brokerages-anticipate-maximus-inc-mms-to-post-0-77-eps.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Get a free copy of the Zacks research report on MAXIMUS (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related stocks with our FREE daily email newsletter.